Nuvalent Officer Plans $949K Stock Sale Following Regular Trading Pattern

Nuvalent Officer Darlene Noci has filed Form 144 indicating intent to sell 12,000 shares of Class A Common Stock through J.P.

Rhea-AI Filing Summary

Nuvalent Officer Darlene Noci has filed Form 144 indicating intent to sell 12,000 shares of Class A Common Stock through J.P. Morgan Securities, with an aggregate market value of $948,840. The sale is planned for June 26, 2025, on the NASDAQ exchange.

The securities were acquired through a stock option exercise on June 26, 2025. The filing reveals a consistent pattern of previous sales by Noci over the past three months:

• March 27, 2025: 4,000 shares ($292,482)
• April 29, 2025: 4,000 shares ($298,232)
• May 29, 2025: 4,000 shares ($285,238)

The sales are part of a Rule 10b5-1 trading plan adopted on November 18, 2024, and will be executed through cashless option exercises within three months of the filing date. Total shares outstanding: 66,373,511.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of NUVL stock is Darlene Noci planning to sell according to the Form 144 filing?

According to the Form 144 filing dated June 28, 2025, Darlene Noci, an officer at Nuvalent (NUVL), plans to sell 12,000 shares of Class A Common stock through J.P. Morgan Securities LLC. The aggregate market value of these shares is $948,840.

What is NUVL officer Darlene Noci's recent trading history in the past 3 months?

Darlene Noci has made consistent monthly sales over the past 3 months: 4,000 shares on March 27, 2025 ($292,482), 4,000 shares on April 29, 2025 ($298,232), and 4,000 shares on May 29, 2025 ($285,238).

How did Darlene Noci acquire the NUVL shares being sold in this Form 144?

The shares were acquired through a Stock Option Exercise from the Issuer (Nuvalent) on June 26, 2025. The filing indicates these sales are from Cashless Option Exercises that will occur within 3 months from the filing date.

Is NUVL executive Darlene Noci's stock sale part of a 10b5-1 trading plan?

Yes, the sales are part of a Rule 10b5-1 trading plan that was adopted on November 18, 2024, as disclosed in the Form 144 filing.

What is the current number of outstanding NUVL shares according to the Form 144?

According to the Form 144 filing, Nuvalent (NUVL) has 66,373,511 shares outstanding as of the filing date June 28, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2025 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001862148
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nuvalent, Inc.
SEC File Number	001-40671
Address of Issuer	One Broadway, 14th floor Cambridge MASSACHUSETTS 02142
Phone	8573577000
Name of Person for Whose Account the Securities are To Be Sold	Darlene Noci
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	J.P. Morgan Securities LLC 390 Madison Avenue 6th Floor New York NY 10017	12000	948840	66373511	06/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	06/26/2025	Stock Option Exercise	Issuer			12000	06/26/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Darlene Noci One Broadway, 14th Floor Cambridge MA 02142	Common	03/27/2025	4000	292482
Darlene Noci One Broadway, 14th Floor Cambridge MA 02142	Common	04/29/2025	4000	298232
Darlene Noci One Broadway, 14th Floor Cambridge MA 02142	Common	05/29/2025	4000	285238

144: Remarks and Signature

Remarks	The sales under this filing are from Cashless Option Exercises that will occur within 3 months from the date of this filing.
Date of Notice	06/26/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Darlene Noci
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)